Diabetes treatment is constantly evolving, with new therapeutic options appearing to improve patient outcomes. Recent research have focused on GLP-1 and GIP receptor agonists, a category of drugs that mimic the actions of naturally occurring hormones involved in bloodglucose regulation. These novel agents demonstrate substantial efficacy in improvi

The management of diabetes is with the emergence of exciting new therapies. Among these, Reta, GLP-1 receptor agonists, Retatrutide, and Trizepatide are gaining significant attention. These medications offer promising mechanisms for controlling blood sugar levels and could improve the lives of individuals living with diabetes. This novel class of